Data / Drug companies / Aluminum Complex
Aluminum Complex drugs: 3 drugs from 44 companies in the FDA NDC directory
Aluminum Complex is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 70 products in this class from 44 companies, covering 3 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on July 16, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 44Companies
- 70Products
- 3Drugs by generic name
Drugs in the Aluminum Complex class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Sucralfate | 63 | 39 |
| Sucralfate oral | 6 | 6 |
| Sucralfate oral suspension | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Advanced Rx of Tennessee, LLC | 4 | tablet | Generic drugs (ANDA) | March 13, 2023 |
| Cardinal Health 107, LLC | 4 | tablet; suspension | Generic drugs (ANDA) | July 10, 2026 |
| A-S Medication Solutions | 3 | tablet | Generic drugs (ANDA) | May 20, 2023 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | February 17, 2020 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | May 20, 2023 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet | Generic drugs (ANDA) | May 20, 2023 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | December 10, 2024 |
| Allergan, Inc. | 2 | tablet; suspension | New drug applications (NDA) | December 16, 1993 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | February 17, 2020 |
| AvKARE | 2 | suspension; tablet | Generic drugs (ANDA) | October 31, 2023 |
| Bryant Ranch Prepack | 2 | tablet; suspension | Generic drugs (ANDA) | July 10, 2024 |
| Chartwell RX, LLC | 2 | suspension; tablet | Generic drugs (ANDA) | April 14, 2025 |
| Direct_Rx | 2 | tablet | Generic drugs (ANDA) | March 2, 2023 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet | Generic drugs (ANDA) | May 20, 2023 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | November 18, 2020 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | February 17, 2020 |
| Safecor Health, LLC | 2 | tablet; suspension | Generic drugs (ANDA) | July 16, 2026 |
| American Health Packaging | 1 | suspension | Generic drugs (ANDA) | August 1, 2023 |
| Amneal Pharmaceuticals LLC | 1 | suspension | Generic drugs (ANDA) | December 2, 2019 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet | Generic drugs (ANDA) | April 22, 2022 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet | Generic drugs (ANDA) | March 2, 2024 |
| Asclemed USA Inc. | 1 | tablet | Generic drugs (ANDA) | November 11, 1996 |
| Atlantic Biologicals Corp. | 1 | suspension | Generic drugs (ANDA) | March 15, 2022 |
| AvPAK | 1 | suspension | Generic drugs (ANDA) | August 31, 2022 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | suspension | Generic drugs (ANDA) | April 14, 2025 |
| Cosette Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | December 19, 2024 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | February 4, 2025 |
| Glenmark Pharmaceuticals Inc., USA | 1 | suspension | Generic drugs (ANDA) | January 5, 2026 |
| Kesin Pharma Corporation | 1 | suspension | Generic drugs (ANDA) | July 1, 2024 |
| Major Pharmaceuticals | 1 | suspension | Generic drugs (ANDA) | June 26, 2024 |
| Mylan Institutional Inc. | 1 | tablet | Generic drugs (ANDA) | September 24, 2013 |
| Mylan Pharmaceuticals Inc. | 1 | tablet | Authorized generics (NDA) | September 25, 2017 |
| Pacific Pharma, Inc. | 1 | suspension | Authorized generics (NDA) | February 1, 2024 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | suspension | Generic drugs (ANDA) | March 15, 2022 |
| Precision Dose, Inc. | 1 | suspension | Generic drugs (ANDA) | January 30, 2025 |
| Redpharm Drug | 1 | tablet | Generic drugs (ANDA) | May 20, 2023 |
| Richmond Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | November 21, 2024 |
| Strides Pharma Science Limited | 1 | suspension | Generic drugs (ANDA) | July 10, 2024 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet | Generic drugs (ANDA) | November 11, 1996 |
| Torrent Pharmaceuticals Limited | 1 | suspension | Generic drugs (ANDA) | September 15, 2025 |
| TruPharma, LLC | 1 | suspension | Generic drugs (ANDA) | April 1, 2024 |
| Viona Pharmaceuticals Inc | 1 | tablet | Generic drugs (ANDA) | May 20, 2023 |
| VistaPharm, LLC | 1 | suspension | Generic drugs (ANDA) | March 15, 2022 |
| Zydus Lifesciences Limited | 1 | tablet | Generic drugs (ANDA) | May 20, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 46 | 65.7% |
| Suspension | 24 | 34.3% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.